Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)

Sinsin Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	85,410	82,376	94,664	84,651	97,850	138,658
Market Cap Growth	-21.25%	-12.98%	11.83%	-13.49%	-29.43%	34.02%
Enterprise Value	129,854	122,361	135,899	130,024	145,574	183,301
Last Close Price	5630.00	5430.00	6170.92	5463.41	6258.03	8867.97
PE Ratio	15.46	16.85	20.23	19.18	-	382.34
PS Ratio	0.80	0.77	0.92	0.92	1.32	2.07
PB Ratio	1.29	1.26	1.53	1.42	1.79	2.47
P/TBV Ratio	1.29	1.26	1.53	1.43	1.80	2.49
P/FCF Ratio	18.71	18.56	-	18.59	-	-
P/OCF Ratio	14.66	13.86	24.09	15.50	4220.66	74.34
EV/Sales Ratio	1.21	1.15	1.33	1.41	1.97	2.73
EV/EBITDA Ratio	10.96	10.97	13.67	14.16	62.51	-
EV/EBIT Ratio	17.22	17.76	22.64	23.96	-	-
EV/FCF Ratio	28.45	27.57	-	28.56	-	-
Debt / Equity Ratio	0.69	0.70	0.72	0.73	0.84	0.81
Debt / EBITDA Ratio	3.86	4.09	4.48	4.73	19.85	-
Debt / FCF Ratio	10.02	10.27	-	9.55	-	-
Asset Turnover	0.83	0.84	0.84	0.78	0.64	0.54
Inventory Turnover	3.81	4.34	4.60	4.98	4.60	3.85
Quick Ratio	0.54	0.56	0.59	0.71	0.76	0.77
Current Ratio	0.87	0.87	0.91	1.06	1.08	1.15
Return on Equity (ROE)	8.55%	7.54%	7.64%	7.62%	-2.61%	0.36%
Return on Assets (ROA)	3.64%	3.39%	3.06%	2.88%	-0.72%	-2.11%
Return on Capital (ROIC)	4.32%	3.96%	3.58%	3.32%	-0.83%	-2.46%
Return on Capital Employed (ROCE)	10.80%	9.80%	8.30%	6.90%	-	-
Earnings Yield	6.47%	5.93%	4.94%	5.21%	-1.51%	0.26%
FCF Yield	5.34%	5.39%	-1.14%	5.38%	-2.72%	-7.29%
Dividend Yield	1.06%	1.10%	-	-	-	-
Payout Ratio	16.48%	18.62%	16.21%	-	-	117.13%
Total Shareholder Return	1.07%	1.10%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.